CNS targeting AAV vectors and methods of use thereof
US9102949B2 · kind B2 · utility
81Cited by
39References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 22, 2011 |
| Grant date | Aug 11, 2015 |
| Priority date | — |
| Expiry date | Apr 22, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2840/007
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention in some aspects relates to recombinant adeno-associated viruses useful for targeting transgenes to CNS tissue, and compositions comprising the same, and methods of use thereof. In some aspects, the invention provides methods and compositions for treating CNS-related disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.